Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT04738149

Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment

A Proof of Concept, Split Study Measuring the Effectiveness of Topical ProstaglandinF2alpha, Microneedling and Excimer Laser in the Treatment of Vitiligo

Sponsor: Medical University of South Carolina

Conditions Vitiligo

Interventions Bimatoprost Excimer laser Microneedling with a dermaroller

Updated 7 times since 2021 Last updated: Aug 3, 2022 Started: Nov 2, 2021 Primary completion: May 15, 2022 Completion: May 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Vitiligo and is currently completed. Medical University of South Carolina leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Sep 2022 — Jul 2024 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
Mar 2022 — Sep 2022 [monthly]

Recruiting EARLY_PHASE1
Nov 2021 — Mar 2022 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jun 2021 — Nov 2021 [monthly]

Not Yet Recruiting EARLY_PHASE1
Mar 2021 — Jun 2021 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of South Carolina

Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charleston, United States